Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on receiving the 2024 annual dividend proposal from the company\'s actual controller and chairman
Ningbo Menova Pharmaceutical Co., Ltd. implementation announcement on share incentive restricted stock repurchase and cancellation
Legal opinion of Shanghai Guangfa Law Firm on matters relating to Ningbo Menova Pharmaceutical Co., Ltd. stock options and restricted stock incentive plans
Menovar: An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan grants stock options for the first time and commences the exercise of rights during the third exercise period
An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan grants stock options for the first time and the commencement of the third exercise period
Menovar: Announcement on the lifting of sales restrictions and listing of restricted stocks during the third sales restriction period granted for the first time in the 2021 Stock Options and Restricted Stock Incentive Plan of Ningbo Menova Pharmaceutical Co., Ltd.
Minovar: Legal Opinions of Shanghai Guangfa Law Firm on matters relating to Ningbo Menohua Pharmaceutical Co., Ltd.\'s 2021 Stock Options and Restricted Stock Incentive Plan
Menovar: Ningbo Menohua Pharmaceutical Co., Ltd. Convertible Debt-to-Stock Exchange Results and Stock Change Announcement
Menovar: Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options Incentive Plan for the fourth quarter of 2024 independent exercise results and share changes
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on independent exercise results and share changes for the fourth quarter of 2024 of the 2021 Stock Options Incentive Plan
Announcement on the lifting of sales restrictions and listing of restricted stocks during the third sales restriction period granted for the first time in the 2021 Stock Options and Restricted Stock Incentive Plan of Ningbo Menova Pharmaceutical Co., Ltd.
Legal opinion of Shanghai Guangfa Law Firm on matters relating to Ningbo Menova Pharmaceutical Co., Ltd.\'s 2021 stock options and restricted stock incentive plan
Menovar: An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan to reserve and grant stock options to commence the second exercise period during the second exercise period
An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan to reserve the grant of stock options to commence the exercise of the second exercise period
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the completion of cancellation of some stock options
Legal opinion of Shanghai Guangfa Law Firm on matters relating to Ningbo Menova Pharmaceutical Co., Ltd.\'s 2021 stock options and restricted stock incentive plan
Announcement on the lifting of sales restrictions and listing of restricted stocks during the second sales restriction period reserved for the 2021 Stock Options and Restricted Stock Incentive Plan of Ningbo Menova Pharmaceutical Co., Ltd.
Legal opinion of Shanghai Guangfa Law Firm on matters relating to Ningbo Menova Pharmaceutical Co., Ltd.\'s 2021 stock options and restricted stock incentive plan
Explanation of the board of directors of Ningbo Menova Pharmaceutical Co., Ltd. on the successive adjustments related to the equity incentive plan
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan grants the third right to lift the sales restriction conditions for the first time and the achievement of reserving the granting of the second right to lift the sales restriction conditions